Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Europe Backs Celgene’s Pomalidomide And Aegerion’s Lomitapide

May 31 2013

• By John Davis

Related Content

Celgene Has A Swift Start For Pomalyst Launch

Apr 25 2013

Multiple Myeloma Market Snapshot: New Combos Offer Greater Longevity, But Payers May Push Back

May 13 2013

EU's CHMP Clears Selincro And Perjeta, Rejects Kynamro And Fanaptum

Dec 14 2012

Teva’s G-CSF Product Clears FDA, Leaving Appeal Of Biosimilar Pathway Uncertain

Sep 03 2012

Teva Wins Ratiopharm For $5 Billion And Gains A Key Foothold In Europe

Mar 22 2010

Uncle Sam's Orders: Emergent Scores $107 Mil. For Anthrax Plant, While Bavarian Nordic Delivers On Smallpox

Jul 16 2010

Related Companies

Bristol Myers Squibb Company

Takeda Pharmaceutical Co. Ltd.

Aegerion Pharmaceuticals, Inc.

Sanofi Genzyme

Ionis Pharmaceuticals, Inc.

Sanofi

Teva Pharmaceutical Industries Ltd.

ratiopharm

Amgen, Inc.

Bioton S.A.

Bioton S.A.

Bavarian Nordic A/S

CSL Limited

Novartis AG

Additional Topics

Europe BioPharmaceutical

More from Europe

More from Geography

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window